Health
New treatment for life-threatening lung condition receives NSF award – News-Medical.Net
A Purdue University-affiliated startup developing a novel treatment for a life-threatening lung condition has won a $256,000 Small Business Technology Transfer…
A Purdue University-affiliated startup developing a novel treatment for a life-threatening lung condition has won a $256,000 Small Business Technology Transfer Phase I award from the National Science Foundation.
Spirrow Therapeutics offers help for patients with acute respiratory distress syndrome, or ARDS, by restoring lung function with a nanopolymer surfactant that can be administered through the trachea as a fast-acting liquid or preemptive aerosol. The startup team also is looking to use the…
-
Noosa News16 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business19 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
Business18 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General18 hours agoDay of pain: sirens ring out to mark attack on Israel